Exploring the emergence of agentic ecosystems in transforming data accessibility and ensuring reliable answers reach the people making decisions while there is still a choice to make.
|Articles|January 16, 2023
DeepIntent Celebrates Year-Over-Year Growth as Marketers Invest in CTV
Advertisement
DeepIntent, a healthcare advertising technology company built to influence better patient health and business outcomes, announced it has reached a significant milestone, achieving growth for the fifth consecutive year and a triple-digit percentage growth rate across connected television (CTV) campaigns.
In 2022, DeepIntent experienced triple-digit growth in CTV investment on its demand side platform, making CTV one of the fastest-growing channels for the hundreds of pharmaceutical brands now using the DeepIntent Healthcare Advertising Platform.
Advertisement
Related to this article
How earlier signals of misconnection may help pharma identify trust breakdowns before they show up as lagging measures in adherence, initiation, engagement, and outcomes.
Advertisement
Advertisement
Trending on PharmExec
1
The Most Important Lessons Learned from Building CGT Supply Chains: LogiPharma 2026
2
Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing
3
Ultragenyx to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
4
FDA Approves Tecentriq for Stage III dMMR Colon Cancer
5